IRCT2017050723235N10已完成3 期
Rush Immunotherapy effects on the gene expression of IL- 4, FoxP3, TGF-ß, IL-17, IL-10 and IFN-? in the perennial allergic rhinitis patients
Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 51 years（—）
- 性别
- All
入选标准
- •The risk of perennial allergic rhinitis; Positive skin test to allergens in the air; Clinical signs associated with skin test
- •Exclusion criteria: History of autoimmune disease; Patients with systemic corticosteroids or immunosuppressive drugs for reasons other than allergic disease on the immune system use to be effective; Pregnancy; Immunocompromised patients, patients who have uncontrolled allergic asthma; Patients with malnutrition; Patients who received beta-blocker drugs; Patients with a history of anaphylaxis; patients With coexisting cardiovascular disease; During treatment, patients who are experiencing systemic reactions; Patients with mental disorders
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Analysis of therapy-induced changes in gene expression, tumorigenicity and invasiveness of circulating, epithelial tumor cells (CETCs)C18C19C20Malignant neoplasm of colonMalignant neoplasm of rectosigmoid junctionMalignant neoplasm of rectumDRKS00015530niversität Bayreuth100
已完成
2 期
ImmunoModulation effects of early therapeutic NORMothermia in febrile severe Septic patientstherapeutic normothermiafever controlimmunomodulationneutrophil chemotaxiscytokinesCD11bmHLA-SepsissepsisDRTCTR20160321001Faculty of Medicine, Chulalongkorn University15
招募中
3 期
Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level studyCTRI/2020/06/025861Department of Ayush Uttarakhand
招募中
不适用
Study protocol for the HARMONY studyKCT0005173Korea Institute of Oriental Medicine200
已完成
4 期
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16